Recent Comments

Comment RSS

Tourette Syndrome News and Research RSS Feed - Tourette Syndrome News and Research

Tourette syndrome (TS) is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. The disorder is named for Dr. Georges Gilles de la Tourette, the pioneering French neurologist who in 1885 first described the condition in an 86-year-old French noblewoman.

The early symptoms of TS are almost always noticed first in childhood, with the average onset between the ages of 7 and 10 years. TS occurs in people from all ethnic groups; males are affected about three to four times more often than females. It is estimated that 200,000 Americans have the most severe form of TS, and as many as one in 100 exhibit milder and less complex symptoms such as chronic motor or vocal tics or transient tics of childhood. Although TS can be a chronic condition with symptoms lasting a lifetime, most people with the condition experience their worst symptoms in their early teens, with improvement occurring in the late teens and continuing into adulthood.

New clinical uses for old hypertension drug leads to several patents

28. October 2009 06:11
University of South Florida neuroscientist R. Douglas Shytle's discovery of successful new clinical uses for mecamylamine, a drug once used to treat hypertension, has led to several issued patents on mecamylamine and related compounds. Earlier this month, Shytle, associate professor and research scientist at the USF Center of Excellence for Aging and Brain Repair and the USF Silver Child Development Center, received the university's 2009 "Excellence in Innovation" award. [More]

Posted in: Medical Patent News | Pharmaceutical News

Tags: , , , , ,

Deep brain stimulation: New treatment option for people with severe Tourette syndrome

27. October 2009 04:06
Deep brain stimulation may be a safe and effective treatment for Tourette syndrome, according to research published in the October 27, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology. [More]

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

15. October 2009 08:20
Writers and producers from The Soloist, "Grey's Anatomy," "United States of Tara," "90210," and others were honored by the Substance Abuse and Mental Health Services Administration (SAMHSA) for increasing awareness of mental health issues and the power of recovery at the 2009 Voice Awards last night. The event was hosted by Academy Award-winning actor and mental health consumer Richard Dreyfuss at Paramount Studios in Los Angeles. [More]

Streptococcal infection does not cause OCD or Tourette syndrome, says study

1. October 2009 02:09
New research shows that streptococcal infection does not appear to cause or trigger Tourette syndrome or obsessive-compulsive disorder (OCD). The research is published in the September 30, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology. [More]

New insights into identifying children at risk for autoimmune brain disorders

11. August 2009 20:54
A new study by researchers at Columbia University Mailman School of Public Health's Center for Infection and Immunity indicates that pediatric obsessive-compulsive disorder (OCD), Tourette syndrome and/or tic disorder may develop from an inappropriate immune response to the bacteria causing common throat infections. [More]

Posted in: Medical Research News

Tags: , , , , , , , ,

Mylan receives FDA approval for additional strengths of antipsychotic Haloperidol

20. July 2009 18:51
Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug Application (ANDA) for Haloperidol Tablets USP, 10 mg and 20 mg. These strengths are in addition to Mylan's currently marketed 0.5 mg, 1 mg, 2 mg and 5 mg strengths of the product. [More]

Posted in: Pharmaceutical News

Tags: , ,

New pieces in the autism inheritance puzzle

30. June 2009 05:31
Pieces in the complex autism inheritance puzzle are emerging in the latest study from a research team including geneticists from the University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia (CHOP). The study identified 27 different genetic regions where rare copy number variations - missing or extra copies of DNA segments - were found in the genes of children with autism spectrum disorders, but not in the healthy controls. The findings are published June 26 in the open-access journal PLoS Genetics. [More]

Posted in: Medical Research News | Medical Condition News

Tags: , , , , ,

Deep brain stimulation for psychiatric disorders

30. June 2009 03:14
Pioneering therapeutic trials to investigate the effectiveness of deep brain stimulation (DBS) in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette's syndrome are underway at multiple medical centers around the world, according to a review in the June 2009 issue of Mayo Clinic Proceedings. [More]

ADHD genes found - missing DNA segments may suggest future drug targets

24. June 2009 05:56
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD. Many of those genes were already known to be important for learning, behavior, brain function and neurodevelopment, but had not been previously associated with ADHD. [More]

Could hormones explain gender differences in neurological disease?

16. June 2009 02:35
Neurological diseases including Parkinson's, Tourette's, attention deficit hyperactivity disorder (ADHD), Alzheimer's, and schizophrenia are all associated with alterations in dopamine-driven function involving the dopamine transporter (DAT). [More]

Biovail acquires worldwide rights to Tetrabenazine

18. May 2009 23:18
Biovail Corporation today announced a wholly owned subsidiary has entered into a definitive agreement to acquire worldwide development and commercialization rights to the entire portfolio of tetrabenazine products, including Xenazine/Nitoman (tetrabenazine tablets), and the associated intellectual property rights held by Cambridge Laboratories (Ireland) Ltd and its affiliates. [More]

Posted in: Pharmaceutical News

Tags: , , , ,

Magnetization Transfer Imaging shows structural changes in Tourette's syndrome

12. May 2009 05:17
Magnetization Transfer Imaging, MTI, has been used to visualize previously unknown alterations in the cerebral architecture of patients with Tourette's syndrome. [More]

Posted in: Medical Research News

Tags: , , , , ,

Researchers examine link between Tourette syndrome and ADHD

15. April 2009 22:13
The most disabling aspect of Tourette syndrome is that in 90% of cases, it exists in conjunction with another disorder. [More]

District Court decision received in Concerta patent sase

1. April 2009 10:40
The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application. [More]

Shire withdraws European application for Daytrana (Methylphenidate Transdermal System)

16. March 2009 22:13
Shire plc has announced that it has decided to withdraw the European Marketing Authorization Application (MAA) for Daytrana (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.